APVO: Aptevo Therapeutics Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | CVI Investments, Inc. | 6.30% | SEC |
Institutional ownership (Q2 2026)
9 institutions reported holding $128K of Aptevo Therapeutics Inc. on Form 13F (9 the quarter before). 1 opened a new position and 0 sold out. Shares held by institutions: -6%.
| Largest holders | Shares | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 12,713 | $56K |
| GEODE CAPITAL MANAGEMENT, LLC | 10,821 | $48K |
| VANGUARD FIDUCIARY TRUST CO | 4,142 | $18K |
| UBS Group AG | 730 | $3K |
| OSAIC HOLDINGS, INC. | 360 | $2K |
| SBI Securities Co., Ltd. | 109 | $484 |
| BARCLAYS PLC | 31 | $138 |
| GSA CAPITAL PARTNERS LLP | 21,539 | $96 |
| DANSKE BANK A/S | 1 | $4 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.